Table 1.
Professional Society Osteoporosis Screening Guidelines
| Professional group | Target population | BMD screening recommendation |
|---|---|---|
| North American Menopause Society11 | Postmenopausal women | Age ≥65 years without risk factors or ≤65 years with risk factors |
| Postmenopausal women with medical causes of bone loss or fragility fracture, regardless of age | ||
| Postmenopausal women ≥50 years with additional risk factors | ||
| National Osteoporosis Foundation,3 American College of Preventive Medicine12 | Postmenopausal women | Age ≥65 years without risk factors or ≤65 years with risk factors |
| Men | Age ≥70 years without risk factors or ≥50 years with risk factors | |
| U.S. Preventive Services Task Force13 | Postmenopausal women | Age ≥65 years or ≤65 years with risk factors |
| Men | Nonea | |
| Institute for Clinical Systems Improvement14 | Postmenopausal women | Age ≥65 years and in younger women whose fracture risk is ≥9.3% from FRAX analysis or are considered to be at risk of fracture |
No recommendations were made for men due to lack of sufficient evidence.
BMD, bone mineral density; FRAX, Fracture Risk Assessment Tool.